Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
bioRxiv ; 2024 Jun 22.
Article in English | MEDLINE | ID: mdl-38915673

ABSTRACT

Certain areas of the brain involved in episodic memory and behavior, such as the hippocampus, express high levels of insulin receptors and glucose transporter-4 (GLUT4) and are responsive to insulin. Insulin and neuronal glucose metabolism improve cognitive functions and regulate mood in humans. Insulin-dependent GLUT4 trafficking has been extensively studied in muscle and adipose tissue, but little work has demonstrated either how it is controlled in insulin-responsive brain regions or its mechanistic connection to cognitive functions. In this study, we demonstrate that inhibition of WNK (With-No-lysine (K)) kinases improves learning and memory in mice. Neuronal inhibition of WNK enhances in vivo hippocampal glucose uptake. Inhibition of WNK enhances insulin signaling output and insulin-dependent GLUT4 trafficking to the plasma membrane in mice primary neuronal cultures and hippocampal slices. Therefore, we propose that the extent of neuronal WNK kinase activity has an important influence on learning, memory and anxiety-related behaviors, in part, by modulation of neuronal insulin signaling.

2.
J Clin Invest ; 133(9)2023 05 01.
Article in English | MEDLINE | ID: mdl-36862513

ABSTRACT

The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown. Here, we demonstrated that salt-inducible kinases (SIKs) orchestrated renal 1,25-vitamin D production downstream of PTH signaling. PTH inhibited SIK cellular activity by cAMP-dependent PKA phosphorylation. Whole-tissue and single-cell transcriptomics demonstrated that both PTH and pharmacologic SIK inhibitors regulated a vitamin D gene module in the proximal tubule. SIK inhibitors increased 1,25-vitamin D production and renal Cyp27b1 mRNA expression in mice and in human embryonic stem cell-derived kidney organoids. Global- and kidney-specific Sik2/Sik3 mutant mice showed Cyp27b1 upregulation, elevated serum 1,25-vitamin D, and PTH-independent hypercalcemia. The SIK substrate CRTC2 showed PTH and SIK inhibitor-inducible binding to key Cyp27b1 regulatory enhancers in the kidney, which were also required for SIK inhibitors to increase Cyp27b1 in vivo. Finally, in a podocyte injury model of chronic kidney disease-mineral bone disorder (CKD-MBD), SIK inhibitor treatment stimulated renal Cyp27b1 expression and 1,25-vitamin D production. Together, these results demonstrated a PTH/SIK/CRTC signaling axis in the kidney that controls Cyp27b1 expression and 1,25-vitamin D synthesis. These findings indicate that SIK inhibitors might be helpful for stimulation of 1,25-vitamin D production in CKD-MBD.


Subject(s)
Chronic Kidney Disease-Mineral and Bone Disorder , Renal Insufficiency, Chronic , Mice , Humans , Animals , Vitamin D/metabolism , Parathyroid Hormone/genetics , Parathyroid Hormone/metabolism , Calcium/metabolism , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/metabolism , Chronic Kidney Disease-Mineral and Bone Disorder/metabolism , Kidney/metabolism , Renal Insufficiency, Chronic/metabolism , Homeostasis , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism
3.
Cell Stem Cell ; 28(12): 2090-2103.e9, 2021 12 02.
Article in English | MEDLINE | ID: mdl-34551362

ABSTRACT

Extracellular vesicles (EVs) transfer complex biologic material between cells. However, the role of this process in vivo is poorly defined. Here, we demonstrate that osteoblastic cells in the bone marrow (BM) niche elaborate extracellular vesicles that are taken up by hematopoietic progenitor cells in vivo. Genotoxic or infectious stress rapidly increased stromal-derived extracellular vesicle transfer to granulocyte-monocyte progenitors. The extracellular vesicles contained processed tRNAs (tiRNAs) known to modulate protein translation. 5'-ti-Pro-CGG-1 was preferentially abundant in osteoblast-derived extracellular vesicles and, when transferred to granulocyte-monocyte progenitors, increased protein translation, cell proliferation, and myeloid differentiation. Upregulating EV transfer improved hematopoietic recovery from genotoxic injury and survival from fungal sepsis. Therefore, EV-mediated tiRNA transfer provides a stress-modulated signaling axis in the BM niche distinct from conventional cytokine-driven stress responses.


Subject(s)
Extracellular Vesicles , Hematopoietic Stem Cells , Bone Marrow , Bone Marrow Cells , Hematopoiesis
4.
Nat Cell Biol ; 21(11): 1449-1461, 2019 11.
Article in English | MEDLINE | ID: mdl-31659274

ABSTRACT

Development and differentiation are associated with profound changes to histone modifications, yet their in vivo function remains incompletely understood. Here, we generated mouse models expressing inducible histone H3 lysine-to-methionine (K-to-M) mutants, which globally inhibit methylation at specific sites. Mice expressing H3K36M developed severe anaemia with arrested erythropoiesis, a marked haematopoietic stem cell defect, and rapid lethality. By contrast, mice expressing H3K9M survived up to a year and showed expansion of multipotent progenitors, aberrant lymphopoiesis and thrombocytosis. Additionally, some H3K9M mice succumbed to aggressive T cell leukaemia/lymphoma, while H3K36M mice exhibited differentiation defects in testis and intestine. Mechanistically, induction of either mutant reduced corresponding histone trimethylation patterns genome-wide and altered chromatin accessibility as well as gene expression landscapes. Strikingly, discontinuation of transgene expression largely restored differentiation programmes. Our work shows that individual chromatin modifications are required at several specific stages of differentiation and introduces powerful tools to interrogate their roles in vivo.


Subject(s)
Epigenesis, Genetic , Histones/metabolism , Leukemia, T-Cell/genetics , Lysine/metabolism , Methionine/metabolism , Teratoma/genetics , Animals , Bone Marrow Transplantation , Cell Lineage/genetics , Disease Models, Animal , Doxycycline/pharmacology , Erythroid Cells/metabolism , Erythroid Cells/pathology , Female , Granulocytes/metabolism , Granulocytes/pathology , Histones/genetics , Leukemia, T-Cell/chemically induced , Leukemia, T-Cell/metabolism , Leukemia, T-Cell/pathology , Male , Methylation , Mice , Mice, Transgenic , Mouse Embryonic Stem Cells/metabolism , Mouse Embryonic Stem Cells/pathology , Mutation , Signal Transduction , Survival Analysis , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Teratoma/chemically induced , Teratoma/metabolism , Teratoma/pathology
5.
Cell Stem Cell ; 25(5): 622-638.e13, 2019 11 07.
Article in English | MEDLINE | ID: mdl-31588046

ABSTRACT

Post-transcriptional mechanisms have the potential to influence complex changes in gene expression, yet their role in cell fate transitions remains largely unexplored. Here, we show that suppression of the RNA helicase DDX6 endows human and mouse primed embryonic stem cells (ESCs) with a differentiation-resistant, "hyper-pluripotent" state, which readily reprograms to a naive state resembling the preimplantation embryo. We further demonstrate that DDX6 plays a key role in adult progenitors where it controls the balance between self-renewal and differentiation in a context-dependent manner. Mechanistically, DDX6 mediates the translational suppression of target mRNAs in P-bodies. Upon loss of DDX6 activity, P-bodies dissolve and release mRNAs encoding fate-instructive transcription and chromatin factors that re-enter the ribosome pool. Increased translation of these targets impacts cell fate by rewiring the enhancer, heterochromatin, and DNA methylation landscapes of undifferentiated cell types. Collectively, our data establish a link between P-body homeostasis, chromatin organization, and stem cell potency.


Subject(s)
Cell Differentiation/genetics , Cell Plasticity/genetics , DEAD-box RNA Helicases/metabolism , Induced Pluripotent Stem Cells/metabolism , Proto-Oncogene Proteins/metabolism , Ribonucleoproteins/metabolism , Animals , Cell Line , Chromatin Assembly and Disassembly/genetics , DEAD-box RNA Helicases/genetics , DNA Methylation , Embryonic Stem Cells/cytology , Embryonic Stem Cells/metabolism , Gene Expression Regulation/genetics , Gene Ontology , Homeostasis/genetics , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/enzymology , Jumonji Domain-Containing Histone Demethylases/genetics , Jumonji Domain-Containing Histone Demethylases/metabolism , Mice , Mice, Inbred C57BL , Nanog Homeobox Protein/metabolism , Organoids/cytology , Organoids/diagnostic imaging , Organoids/metabolism , Protein Biosynthesis/genetics , Proteins/metabolism , Proto-Oncogene Proteins/genetics , RNA, Messenger/metabolism , RNA-Seq , Ribonucleoproteins/genetics , Ribosomes/metabolism
6.
Neuron ; 103(5): 820-835.e7, 2019 09 04.
Article in English | MEDLINE | ID: mdl-31301936

ABSTRACT

The microglial receptors CD33 and TREM2 have been associated with risk for Alzheimer's disease (AD). Here, we investigated crosstalk between CD33 and TREM2. We showed that knockout of CD33 attenuated amyloid beta (Aß) pathology and improved cognition in 5xFAD mice, both of which were abrogated by additional TREM2 knockout. Knocking out TREM2 in 5xFAD mice exacerbated Aß pathology and neurodegeneration but reduced Iba1+ cell numbers, all of which could not be rescued by additional CD33 knockout. RNA-seq profiling of microglia revealed that genes related to phagocytosis and signaling (IL-6, IL-8, acute phase response) are upregulated in 5xFAD;CD33-/- and downregulated in 5xFAD;TREM2-/- mice. Differential gene expression in 5xFAD;CD33-/- microglia depended on the presence of TREM2, suggesting TREM2 acts downstream of CD33. Crosstalk between CD33 and TREM2 includes regulation of the IL-1ß/IL-1RN axis and a gene set in the "receptor activity chemokine" cluster. Our results should facilitate AD therapeutics targeting these receptors.


Subject(s)
Alzheimer Disease/genetics , Amyloid beta-Peptides/metabolism , Brain/metabolism , Cognition , Membrane Glycoproteins/genetics , Microglia/metabolism , Plaque, Amyloid/pathology , Receptors, Immunologic/genetics , Sialic Acid Binding Ig-like Lectin 3/genetics , Acute-Phase Reaction/genetics , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Brain/pathology , Disease Models, Animal , Gene Expression Regulation , Interleukin-6/metabolism , Interleukin-8/metabolism , Mice , Mice, Knockout , Microglia/pathology , Phagocytosis/genetics
7.
Sci Rep ; 9(1): 7029, 2019 05 07.
Article in English | MEDLINE | ID: mdl-31065051

ABSTRACT

Celiac disease (CD) is an immune-mediated disorder triggered by gluten exposure. The contribution of the adaptive immune response to CD pathogenesis has been extensively studied, but the absence of valid experimental models has hampered our understanding of the early steps leading to loss of gluten tolerance. Using intestinal organoids developed from duodenal biopsies from both non-celiac (NC) and celiac (CD) patients, we explored the contribution of gut epithelium to CD pathogenesis and the role of microbiota-derived molecules in modulating the epithelium's response to gluten. When compared to NC, RNA sequencing of CD organoids revealed significantly altered expression of genes associated with gut barrier, innate immune response, and stem cell functions. Monolayers derived from CD organoids exposed to gliadin showed increased intestinal permeability and enhanced secretion of pro-inflammatory cytokines compared to NC controls. Microbiota-derived bioproducts butyrate, lactate, and polysaccharide A improved barrier function and reduced gliadin-induced cytokine secretion. We concluded that: (1) patient-derived organoids faithfully express established and newly identified molecular signatures characteristic of CD. (2) microbiota-derived bioproducts can be used to modulate the epithelial response to gluten. Finally, we validated the use of patient-derived organoids monolayers as a novel tool for the study of CD.


Subject(s)
Celiac Disease/microbiology , Gastrointestinal Microbiome/physiology , Intestinal Mucosa/cytology , Organoids , Adult , Aged , Celiac Disease/genetics , Celiac Disease/pathology , Cell Proliferation , Cytokines/metabolism , Duodenum/cytology , Duodenum/pathology , Dysbiosis/metabolism , Gastrointestinal Microbiome/genetics , Gene Expression , Gliadin/metabolism , Gliadin/pharmacology , Glutens/metabolism , Glutens/pharmacology , Humans , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Middle Aged , Reproducibility of Results , Stem Cells/pathology
8.
Elife ; 82019 01 24.
Article in English | MEDLINE | ID: mdl-30676316

ABSTRACT

The zinc finger CCCTC-binding protein (CTCF) carries out many functions in the cell. Although previous studies sought to explain CTCF multivalency based on sequence composition of binding sites, few examined how CTCF post-translational modification (PTM) could contribute to function. Here, we performed CTCF mass spectrometry, identified a novel phosphorylation site at Serine 224 (Ser224-P), and demonstrate that phosphorylation is carried out by Polo-like kinase 1 (PLK1). CTCF Ser224-P is chromatin-associated, mapping to at least a subset of known CTCF sites. CTCF Ser224-P accumulates during the G2/M transition of the cell cycle and is enriched at pericentric regions. The phospho-obviation mutant, S224A, appeared normal. However, the phospho-mimic mutant, S224E, is detrimental to mouse embryonic stem cell colonies. While ploidy and chromatin architecture appear unaffected, S224E mutants differentially express hundreds of genes, including p53 and p21. We have thus identified a new CTCF PTM and provided evidence of biological function.


Subject(s)
CCCTC-Binding Factor/metabolism , Cell Cycle Proteins/metabolism , G2 Phase , Mitosis , Phosphoserine/metabolism , Protein Processing, Post-Translational , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Amino Acid Sequence , Animals , Base Sequence , CCCTC-Binding Factor/chemistry , Casein Kinase II/metabolism , Cell Proliferation , Chromatin , Conserved Sequence , DNA/metabolism , DNA Mutational Analysis , Humans , Interphase , Membrane Proteins/metabolism , Mice , Mutation/genetics , Phosphorylation , Ploidies , Protein Binding , RNA/metabolism , Signal Transduction , Tumor Suppressor Protein p53/metabolism , Up-Regulation , Polo-Like Kinase 1
9.
Genes Dev ; 32(9-10): 670-681, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29739806

ABSTRACT

RNAi pathways detect and silence foreign nucleic acids such as viruses as well as endogenous genes in many species. The phylogenetic profile across eukaryotes of proteins that mediate key steps in RNAi is correlated with the profiles of multiple mRNA splicing proteins and with intron number, suggesting that RNAi may surveil mRNA splicing to detect the divergent or absent introns of viruses. Here we examine the role of mRNA splicing in Caenorhabditis elegans RNAi. We found that viable null mutations in U1 and U2 small nuclear ribonucleic protein (snRNP)-specific splicing factor genes cause defects in RNAi. The U1A ortholog rnp-2 is required for normal ERGO-1 Argonaute class 26G siRNA biogenesis, trans-splicing of the eri-6/7 transcript, and targeting of poorly conserved gene transcripts by WAGO Argonaute class 22G siRNAs. We found that gene transcripts engaged by the siRNA-generating machinery are poorly conserved, possess few introns, and often have introns that are divergent from introns with strong consensus splicing sites found in highly conserved genes. We present biochemical evidence that RNAi targeted transcripts are tightly bound to spliceosomes. These findings suggest multiple layers of regulation by the spliceosome at early steps of small RNA-mediated gene silencing.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/genetics , RNA Interference/physiology , RNA Precursors/metabolism , RNA Splicing , Animals , Gene Expression Regulation/genetics , Introns/genetics , Mutation , RNA Splicing Factors/genetics , RNA, Small Nuclear/genetics , Spliceosomes/metabolism
10.
Stem Cell Reports ; 10(5): 1505-1521, 2018 05 08.
Article in English | MEDLINE | ID: mdl-29742392

ABSTRACT

Skeletal muscle harbors quiescent stem cells termed satellite cells and proliferative progenitors termed myoblasts, which play pivotal roles during muscle regeneration. However, current technology does not allow permanent capture of these cell populations in vitro. Here, we show that ectopic expression of the myogenic transcription factor MyoD, combined with exposure to small molecules, reprograms mouse fibroblasts into expandable induced myogenic progenitor cells (iMPCs). iMPCs express key skeletal muscle stem and progenitor cell markers including Pax7 and Myf5 and give rise to dystrophin-expressing myofibers upon transplantation in vivo. Notably, a subset of transplanted iMPCs maintain Pax7 expression and sustain serial regenerative responses. Similar to satellite cells, iMPCs originate from Pax7+ cells and require Pax7 itself for maintenance. Finally, we show that myogenic progenitor cell lines can be established from muscle tissue following small-molecule exposure alone. This study thus reports on a robust approach to derive expandable myogenic stem/progenitor-like cells from multiple cell types.


Subject(s)
Cellular Reprogramming , Fibroblasts/cytology , Muscle, Skeletal/cytology , Stem Cells/cytology , Animals , Biomarkers/metabolism , Cell Differentiation/drug effects , Cell Self Renewal/drug effects , Cellular Reprogramming/drug effects , Fibroblasts/drug effects , Mice , Muscle Development/drug effects , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/pathology , Muscular Dystrophy, Animal/pathology , MyoD Protein/metabolism , PAX7 Transcription Factor/metabolism , Regeneration/drug effects , Satellite Cells, Skeletal Muscle/metabolism , Small Molecule Libraries/pharmacology , Stem Cell Niche/drug effects , Stem Cell Transplantation , Stem Cells/drug effects , Transgenes
11.
Dev Cell ; 43(3): 359-371.e6, 2017 11 06.
Article in English | MEDLINE | ID: mdl-29107559

ABSTRACT

X-chromosome inactivation (XCI) silences one X chromosome in the female mammal and is essential to peri-implantation development. XCI is thought to be cell autonomous, with all factors required being produced within each cell. Nevertheless, external cues may exist. Here, we search for such developmental signals by combining bioinformatic, biochemical, and genetic approaches. Using ex vivo and in vivo models, we identify the Hedgehog (HH) paracrine system as a candidate signaling cascade. HH signaling keeps XCI in check in pluripotent cells and is transduced by GLI transcription factors to binding sites in Tsix, the antisense repressor of XCI. GLI potentiates Tsix expression and impedes XCI. In vivo, mutating Indian Hedgehog results in a sex ratio bias against females, and the female lethality is rescued by a second-site mutation in Tsix. These data demonstrate a genetic and functional intersection between HH and XCI and support a role for intercellular signaling during XCI.


Subject(s)
Hedgehog Proteins/metabolism , Promoter Regions, Genetic/genetics , RNA, Long Noncoding/genetics , X Chromosome Inactivation/genetics , Animals , Cell Differentiation/physiology , Female , Mice, Knockout , Transcription Factors/metabolism , Transcription, Genetic/genetics
12.
Mol Cell ; 68(5): 872-884.e6, 2017 Dec 07.
Article in English | MEDLINE | ID: mdl-29153392

ABSTRACT

Polycomb repressive complex 2 (PRC2-EZH2) methylates histone H3 at lysine 27 (H3K27) and is required to maintain gene repression during development. Misregulation of PRC2 is linked to a range of neoplastic malignancies, which is believed to involve methylation of H3K27. However, the full spectrum of non-histone substrates of PRC2 that might also contribute to PRC2 function is not known. We characterized the target recognition specificity of the PRC2 active site and used the resultant data to screen for uncharacterized potential targets. The RNA polymerase II (Pol II) transcription elongation factor, Elongin A (EloA), is methylated by PRC2 in vivo. Mutation of the methylated EloA residue decreased repression of a subset of PRC2 target genes as measured by both steady-state and nascent RNA levels and perturbed embryonic stem cell differentiation. We propose that PRC2 modulates transcription of a subset of low expression target genes in part via methylation of EloA.


Subject(s)
Cell Differentiation , DNA Methylation , Elongin/metabolism , Embryonic Stem Cells/metabolism , Epigenesis, Genetic , Histones/metabolism , Polycomb Repressive Complex 2/metabolism , Transcription, Genetic , 3T3-L1 Cells , Animals , Elongin/genetics , Gene Expression Regulation, Developmental , Histones/genetics , Mice , Mutation , Polycomb Repressive Complex 2/genetics , Transfection
13.
Nat Commun ; 8: 15142, 2017 05 09.
Article in English | MEDLINE | ID: mdl-28485378

ABSTRACT

PHF8 is a histone demethylase with specificity for repressive modifications. While mutations of PHF8 have been associated with cognitive defects and cleft lip/palate, its role in mammalian development and physiology remains unexplored. Here, we have generated a Phf8 knockout allele in mice to examine the consequences of Phf8 loss for development and behaviour. Phf8 deficient mice neither display obvious developmental defects nor signs of cognitive impairment. However, we report a striking resiliency to stress-induced anxiety- and depression-like behaviour on loss of Phf8. We further observe misregulation of serotonin signalling within the prefrontal cortex of Phf8 deficient mice and identify the serotonin receptors Htr1a and Htr2a as direct targets of PHF8. Our results clarify the functional role of Phf8 in mammalian development and behaviour and establish a direct link between Phf8 expression and serotonin signalling, identifying this histone demethylase as a potential target for the treatment of anxiety and depression.


Subject(s)
Anxiety/metabolism , Behavior, Animal , Depression/metabolism , Histone Demethylases/deficiency , Histone Demethylases/metabolism , Resilience, Psychological , Transcription Factors/deficiency , Transcription Factors/metabolism , Alleles , Animals , Anxiety/pathology , Anxiety/physiopathology , Cognitive Dysfunction/pathology , Cognitive Dysfunction/physiopathology , Depression/pathology , Depression/physiopathology , Gene Deletion , Mice , Mice, Knockout , Mouse Embryonic Stem Cells/metabolism , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , Receptors, Serotonin/metabolism , Stress, Psychological/physiopathology
14.
Elife ; 62017 05 06.
Article in English | MEDLINE | ID: mdl-28477407

ABSTRACT

Shank is a post-synaptic scaffolding protein that has many binding partners. Shank mutations and copy number variations (CNVs) are linked to several psychiatric disorders, and to synaptic and behavioral defects in mice. It is not known which Shank binding partners are responsible for these defects. Here we show that the C. elegans SHN-1/Shank binds L-type calcium channels and that increased and decreased shn-1 gene dosage alter L-channel current and activity-induced expression of a CRH-1/CREB transcriptional target (gem-4 Copine), which parallels the effects of human Shank copy number variations (CNVs) on Autism spectrum disorders and schizophrenia. These results suggest that an important function of Shank proteins is to regulate L-channel current and activity induced gene expression.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Calcium Channels, L-Type/metabolism , Calcium/metabolism , Cations, Divalent/metabolism , Cyclic AMP Response Element-Binding Protein/metabolism , Transcription Factors/metabolism , Animals , Caenorhabditis elegans , Muscles/physiology
15.
Front Microbiol ; 8: 240, 2017.
Article in English | MEDLINE | ID: mdl-28265266

ABSTRACT

Flaviviral infections including dengue virus are an increasing clinical problem worldwide. Dengue infection triggers host production of the type 1 IFN, IFN alpha, one of the strongest and broadest acting antivirals known. However, dengue virus subverts host IFN signaling at early steps of IFN signal transduction. This subversion allows unbridled viral replication which subsequently triggers ongoing production of IFN which, again, is subverted. Identification of downstream IFN antiviral effectors will provide targets which could be activated to restore broad acting antiviral activity, stopping the signal to produce endogenous IFN at toxic levels. To this end, we performed a targeted functional genomic screen for IFN antiviral effector genes (IEGs), identifying 56 IEGs required for antiviral effects of IFN against fully infectious dengue virus. Dengue IEGs were enriched for genes encoding nuclear receptor interacting proteins, including HELZ2, MAP2K4, SLC27A2, HSP90AA1, and HSP90AB1. We focused on HELZ2 (Helicase With Zinc Finger 2), an IFN stimulated gene and IEG which encodes a promiscuous nuclear factor coactivator that exists in two isoforms. The two unique HELZ2 isoforms are both IFN responsive, contain ISRE elements, and gene products increase in the nucleus upon IFN stimulation. Chromatin immunoprecipitation-sequencing revealed that the HELZ2 complex interacts with triglyceride-regulator LMF1. Mass spectrometry revealed that HELZ2 knockdown cells are depleted of triglyceride subsets. We thus sought to determine whether HELZ2 interacts with a nuclear receptor known to regulate immune response and lipid metabolism, AHR, and identified HELZ2:AHR interactions via co-immunoprecipitation, found that AHR is a dengue IEG, and that an AHR ligand, FICZ, exhibits anti-dengue activity. Primary bone marrow derived macrophages from HELZ2 knockout mice, compared to wild type controls, exhibit enhanced dengue infectivity. Overall, these findings reveal that IFN antiviral response is mediated by HELZ2 transcriptional upregulation, enrichment of HELZ2 protein levels in the nucleus, and activation of a transcriptional program that appears to modulate intracellular lipid state. IEGs identified in this study may serve as both (1) potential targets for host directed antiviral design, downstream of the common flaviviral subversion point, as well as (2) possible biomarkers, whose variation, natural, or iatrogenic, could affect host response to viral infections.

17.
Clin Infect Dis ; 64(7): 930-938, 2017 Apr 01.
Article in English | MEDLINE | ID: mdl-28077518

ABSTRACT

BACKGROUND: Control of Lyme disease is attributed predominantly to innate and adaptive T-helper 1 cell (TH1) immune responses, whereas the role of T-helper 17 cell (TH17) responses is less clear. Here we characterized these inflammatory responses in patients with erythema migrans (EM) or Lyme arthritis (LA) to elucidate their role early and late in the infection. METHODS: Levels of 21 cytokines and chemokines, representative of innate, TH1, and TH17 immune responses, were assessed by Luminex in acute and convalescent sera from 91 EM patients, in serum and synovial fluid from 141 LA patients, and in serum from 57 healthy subjects. Antibodies to Borrelia burgdorferi or autoantigens were measured by enzyme-linked immunosorbent assay. RESULTS: Compared with healthy subjects, EM patients had significantly higher levels of innate, TH1, and TH17-associated mediators (P ≤ .05) in serum. In these patients, the levels of inflammatory mediators, particularly TH17-associated cytokines, correlated directly with B. burgdorferi immunoglobulin G antibodies (P ≤ .02), suggesting a beneficial role for these responses in control of early infection. Late in the disease, in patients with LA, innate and TH1-associated mediators were often >10-fold higher in synovial fluid than serum. In contrast, the levels of TH17-associated mediators were more variable, but correlated strongly with autoantibodies to endothelial cell growth factor, matrix metalloproteinase 10, and apolipoprotein B-100 in joints of patients with antibiotic-refractory LA, implying a shift in TH17 responses toward an autoimmune phenotype. CONCLUSIONS: Patients with Lyme disease often develop pronounced TH17 immune responses that may help control early infection. However, late in the disease, excessive TH17 responses may be disadvantageous by contributing to autoimmune responses associated with antibiotic-refractory LA.


Subject(s)
Antibodies, Bacterial/immunology , Autoantibodies/immunology , Borrelia burgdorferi/immunology , Cytokines/metabolism , Lyme Disease/immunology , Lyme Disease/metabolism , Th17 Cells/metabolism , Adaptive Immunity , Antibodies, Bacterial/blood , Arthritis/etiology , Arthritis/pathology , Autoantigens/immunology , Autoimmunity , Biomarkers , Cytokines/blood , Female , Glossitis, Benign Migratory/etiology , Glossitis, Benign Migratory/metabolism , Humans , Immunity, Innate , Inflammation Mediators/blood , Inflammation Mediators/metabolism , Lyme Disease/complications , Lyme Disease/microbiology , Male , Th17 Cells/immunology
18.
BMC Biol ; 14(1): 105, 2016 12 07.
Article in English | MEDLINE | ID: mdl-27927200

ABSTRACT

BACKGROUND: Many pathogens secrete toxins that target key host processes resulting in the activation of immune pathways. The secreted Pseudomonas aeruginosa toxin Exotoxin A (ToxA) disrupts intestinal protein synthesis, which triggers the induction of a subset of P. aeruginosa-response genes in the nematode Caenorhabditis elegans. RESULTS: We show here that one ToxA-induced C. elegans gene, the Tribbles pseudokinase ortholog nipi-3, is essential for host survival following exposure to P. aeruginosa or ToxA. We find that NIPI-3 mediates the post-developmental expression of intestinal immune genes and proteins and primarily functions in parallel to known immune pathways, including p38 MAPK signaling. Through mutagenesis screening, we identify mutants of the bZIP C/EBP transcription factor cebp-1 that suppress the hypersusceptibility defects of nipi-3 mutants. CONCLUSIONS: NIPI-3 is a negative regulator of CEBP-1, which in turn negatively regulates protective immune mechanisms. This pathway represents a previously unknown innate immune signaling pathway in intestinal epithelial cells that is involved in the surveillance of cellular homeostasis. Because NIPI-3 and CEBP-1 are also essential for C. elegans development, NIPI-3 is analogous to other key innate immune signaling molecules such as the Toll receptors in Drosophila that have an independent role during development.


Subject(s)
CCAAT-Enhancer-Binding Proteins/metabolism , Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/genetics , Immunity, Innate , Protein Kinases/metabolism , ADP Ribose Transferases/metabolism , Animals , Bacterial Toxins/metabolism , Basic-Leucine Zipper Transcription Factors/genetics , Basic-Leucine Zipper Transcription Factors/metabolism , CCAAT-Enhancer-Binding Proteins/genetics , Caenorhabditis elegans/immunology , Caenorhabditis elegans Proteins/genetics , Exotoxins/metabolism , Gastrointestinal Microbiome , Gene Expression Regulation , Intestinal Mucosa/metabolism , Intestines/microbiology , Protein Biosynthesis , Protein Kinases/genetics , Pseudomonas aeruginosa , Signal Transduction , Virulence Factors/metabolism , p38 Mitogen-Activated Protein Kinases/genetics , p38 Mitogen-Activated Protein Kinases/metabolism , Pseudomonas aeruginosa Exotoxin A
19.
J Exp Med ; 213(12): 2575-2589, 2016 11 14.
Article in English | MEDLINE | ID: mdl-27810924

ABSTRACT

Cell transplantation into immunodeficient mice has revolutionized our understanding of regeneration, stem cell self-renewal, and cancer; yet models for direct imaging of engrafted cells has been limited. Here, we characterize zebrafish with mutations in recombination activating gene 2 (rag2), DNA-dependent protein kinase (prkdc), and janus kinase 3 (jak3). Histology, RNA sequencing, and single-cell transcriptional profiling of blood showed that rag2 hypomorphic mutant zebrafish lack T cells, whereas prkdc deficiency results in loss of mature T and B cells and jak3 in T and putative Natural Killer cells. Although all mutant lines engraft fluorescently labeled normal and malignant cells, only the prkdc mutant fish reproduced as homozygotes and also survived injury after cell transplantation. Engraftment into optically clear casper, prkdc-mutant zebrafish facilitated dynamic live cell imaging of muscle regeneration, repopulation of muscle stem cells within their endogenous niche, and muscle fiber fusion at single-cell resolution. Serial imaging approaches also uncovered stochasticity in fluorescently labeled leukemia regrowth after competitive cell transplantation into prkdc mutant fish, providing refined models to assess clonal dominance and progression in the zebrafish. Our experiments provide an optimized and facile transplantation model, the casper, prkdc mutant zebrafish, for efficient engraftment and direct visualization of fluorescently labeled normal and malignant cells at single-cell resolution.


Subject(s)
DNA-Activated Protein Kinase/deficiency , Imaging, Three-Dimensional/methods , Neoplasm Transplantation , Optical Phenomena , Single-Cell Analysis/methods , Zebrafish/metabolism , Anemia/pathology , Animals , Base Sequence , Clone Cells , DNA-Activated Protein Kinase/metabolism , Disease Models, Animal , Gamma Rays , Homozygote , Humans , Immunocompromised Host/radiation effects , Luminescent Proteins/metabolism , Muscle Cells/pathology , Muscle Cells/radiation effects , Mutation/genetics , Proto-Oncogene Proteins c-myc/metabolism , Regeneration/radiation effects , Transplantation, Homologous , V(D)J Recombination/genetics , Zebrafish Proteins/metabolism , Red Fluorescent Protein
20.
Nat Commun ; 7: 13176, 2016 10 19.
Article in English | MEDLINE | ID: mdl-27759007

ABSTRACT

Parathyroid hormone (PTH) activates receptors on osteocytes to orchestrate bone formation and resorption. Here we show that PTH inhibition of SOST (sclerostin), a WNT antagonist, requires HDAC4 and HDAC5, whereas PTH stimulation of RANKL, a stimulator of bone resorption, requires CRTC2. Salt inducible kinases (SIKs) control subcellular localization of HDAC4/5 and CRTC2. PTH regulates both HDAC4/5 and CRTC2 localization via phosphorylation and inhibition of SIK2. Like PTH, new small molecule SIK inhibitors cause decreased phosphorylation and increased nuclear translocation of HDAC4/5 and CRTC2. SIK inhibition mimics many of the effects of PTH in osteocytes as assessed by RNA-seq in cultured osteocytes and following in vivo administration. Once daily treatment with the small molecule SIK inhibitor YKL-05-099 increases bone formation and bone mass. Therefore, a major arm of PTH signalling in osteocytes involves SIK inhibition, and small molecule SIK inhibitors may be applied therapeutically to mimic skeletal effects of PTH.


Subject(s)
Bone and Bones/drug effects , Osteocytes/drug effects , Osteogenesis/drug effects , Parathyroid Hormone/pharmacology , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/genetics , Active Transport, Cell Nucleus/drug effects , Adaptor Proteins, Signal Transducing , Animals , Bone and Bones/cytology , Bone and Bones/metabolism , Gene Expression Regulation , Glycoproteins/antagonists & inhibitors , Glycoproteins/genetics , Glycoproteins/metabolism , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Humans , Intercellular Signaling Peptides and Proteins , Mice , Mice, Knockout , Osteocytes/cytology , Osteocytes/metabolism , Osteogenesis/genetics , Parathyroid Hormone/metabolism , Phosphorylation/drug effects , Primary Cell Culture , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/metabolism , RANK Ligand/antagonists & inhibitors , RANK Ligand/genetics , RANK Ligand/metabolism , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Signal Transduction , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...